Roivant Sciences (ROIV) Current Assets (2021 - 2026)
Roivant Sciences (ROIV) reported Current Assets of $4.74 billion for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 2.7% from $4.62 billion a year earlier but down 8.2% from the prior quarter.
Roivant Sciences (ROIV) Current Assets (2021 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Roivant Sciences posted Current Assets of $5.17 billion, up 3.3% from FY2025.
- Current Assets has a five-year compound annual growth rate of 18.8% (FY2021 to FY2026).
- By fiscal year, Current Assets came in at $5 billion in FY2025 (-25.7%), $6.73 billion in FY2024 (+274.3%), $1.8 billion in FY2023 (-16.2%) and $2.15 billion in FY2022 (-1.9%).
- Five-year quarterly Current Assets spans a low of $1.55 billion in fiscal Q2 2024 and a high of $6.81 billion in fiscal Q3 2024.
- Year over year, Current Assets gained in three of the last eight quarters, with growth averaging 21.8%.
- The high point for year-over-year Current Assets in five years was fiscal Q3 2024 (growth of 313.5%); the low point was fiscal Q2 2023 (a decline of 32.9%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $5.17 billion (Q4 2026), $4.66 billion (Q3 2026) and $4.51 billion (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Roivant Sciences | 26.72 Bn | 27.41 Bn | 1.16 Mn | 4.74 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.74 Bn |
| Mar 31, 2026 | 5.17 Bn |
| Dec 31, 2025 | 4.66 Bn |
| Sep 30, 2025 | 4.51 Bn |
| Jun 30, 2025 | 4.62 Bn |
| Mar 31, 2025 | 5.00 Bn |
| Dec 31, 2024 | 5.36 Bn |
| Sep 30, 2024 | 5.80 Bn |
| Jun 30, 2024 | 6.00 Bn |
| Mar 31, 2024 | 6.73 Bn |
| Dec 31, 2023 | 6.81 Bn |
| Sep 30, 2023 | 1.55 Bn |
| Jun 30, 2023 | 1.56 Bn |
| Mar 31, 2023 | 1.80 Bn |
| Dec 31, 2022 | 1.65 Bn |
| Sep 30, 2022 | 1.71 Bn |
| Jun 30, 2022 | 2.04 Bn |
| Mar 31, 2022 | 2.15 Bn |
| Dec 31, 2021 | 2.29 Bn |
| Sep 30, 2021 | 2.56 Bn |
Roivant Sciences Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ROIV&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();